A comprehensive umbrella review published in the Journal of Psychopharmacology has moderated expectations regarding psychedelic microdosing's effects on mood and cognitive function. The analysis synthesizes existing research to provide a more nuanced understanding of microdosing's actual therapeutic potential compared to popular claims. While some studies suggest modest benefits for depression and anxiety, the evidence remains limited and inconsistent across different populations. Healthcare providers in Puerto Rico should consider these findings when discussing psychedelic-assisted therapies with patients seeking alternative mental health treatments.
